ArticleCancer diagnosis & prognosis

Efficacy of Durvalumab-Tremelimumab Treatment in Combination With Locoregional Therapy in Unresectable Hepatocellular Carcinoma: A Preliminary Study.

Toru Ishikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.